Logo image of BALYO.PA

BALYO SA - PROMESSES (BALYO.PA) Stock Fundamental Analysis

EPA:BALYO - Euronext Paris - Matif - FR0013258399 - Common Stock - Currency: EUR

0.392  -0.01 (-1.75%)

Fundamental Rating

2

Taking everything into account, BALYO scores 2 out of 10 in our fundamental rating. BALYO was compared to 103 industry peers in the Machinery industry. BALYO has a bad profitability rating. Also its financial health evaluation is rather negative. BALYO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BALYO had negative earnings in the past year.
BALYO had a negative operating cash flow in the past year.
In the past 5 years BALYO always reported negative net income.
In the past 5 years BALYO always reported negative operating cash flow.
BALYO.PA Yearly Net Income VS EBIT VS OCF VS FCFBALYO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

BALYO has a worse Return On Assets (-23.70%) than 88.35% of its industry peers.
With a Return On Equity value of -90.59%, BALYO is not doing good in the industry: 90.29% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -23.7%
ROE -90.59%
ROIC N/A
ROA(3y)-22.13%
ROA(5y)-19.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BALYO.PA Yearly ROA, ROE, ROICBALYO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

The Gross Margin of BALYO (30.78%) is worse than 65.05% of its industry peers.
In the last couple of years the Gross Margin of BALYO has grown nicely.
The Profit Margin and Operating Margin are not available for BALYO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y37.21%
BALYO.PA Yearly Profit, Operating, Gross MarginsBALYO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

3

2. Health

2.1 Basic Checks

BALYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
BALYO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BALYO has been increased compared to 5 years ago.
Compared to 1 year ago, BALYO has an improved debt to assets ratio.
BALYO.PA Yearly Shares OutstandingBALYO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BALYO.PA Yearly Total Debt VS Total AssetsBALYO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that BALYO is in the distress zone and has some risk of bankruptcy.
BALYO has a worse Altman-Z score (0.56) than 77.67% of its industry peers.
BALYO has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
BALYO has a Debt to Equity ratio (0.48) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACC7.04%
BALYO.PA Yearly LT Debt VS Equity VS FCFBALYO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

BALYO has a Current Ratio of 1.56. This is a normal value and indicates that BALYO is financially healthy and should not expect problems in meeting its short term obligations.
BALYO's Current ratio of 1.56 is in line compared to the rest of the industry. BALYO outperforms 46.60% of its industry peers.
A Quick Ratio of 1.25 indicates that BALYO should not have too much problems paying its short term obligations.
BALYO has a better Quick ratio (1.25) than 67.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.25
BALYO.PA Yearly Current Assets VS Current LiabilitesBALYO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.42% over the past year.
BALYO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.18%.
The Revenue has been growing slightly by 7.34% on average over the past years.
EPS 1Y (TTM)12.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.78%
Revenue 1Y (TTM)9.18%
Revenue growth 3Y10.17%
Revenue growth 5Y7.34%
Sales Q2Q%30.11%

3.2 Future

BALYO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.47% yearly.
BALYO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.08% yearly.
EPS Next Y9.52%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.83%
Revenue Next 2Y4.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BALYO.PA Yearly Revenue VS EstimatesBALYO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
BALYO.PA Yearly EPS VS EstimatesBALYO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALYO. In the last year negative earnings were reported.
Also next year BALYO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALYO.PA Price Earnings VS Forward Price EarningsBALYO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BALYO.PA Per share dataBALYO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as BALYO's earnings are expected to grow with 15.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BALYO!.
Industry RankSector Rank
Dividend Yield N/A

BALYO SA - PROMESSES

EPA:BALYO (6/27/2025, 7:00:00 PM)

0.392

-0.01 (-1.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-17 2025-07-17
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.93%
Ins Owner ChangeN/A
Market Cap65.52M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.25
P/FCF N/A
P/OCF N/A
P/B 4.46
P/tB 4.51
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.17
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.7%
ROE -90.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.78%
FCFM N/A
ROA(3y)-22.13%
ROA(5y)-19.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y37.21%
F-Score3
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.93%
Cap/Sales 1.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.25
Altman-Z 0.56
F-Score3
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)26.67%
Cap/Depr(5y)22.95%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.78%
EPS Next Y9.52%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.18%
Revenue growth 3Y10.17%
Revenue growth 5Y7.34%
Sales Q2Q%30.11%
Revenue Next Year-20.83%
Revenue Next 2Y4.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-744.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-774.68%
OCF growth 3YN/A
OCF growth 5YN/A